Search clinical trials for: BI VR CBT

Total 6271 results

Baxalta now part of Shire

Completed

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Hemophilia A | Hemophilia B

Japan, Russian Federation, Spain, United States, Poland, Romania, Serbia, Taiwan, Ukraine
University of Arizona
American Academy of Sleep Medicine

Unknown

Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia

Insomnia

United States
Syracuse VA Medical Center
National Development and Research Institutes, Inc.

Completed

Peer Supported Web-based CBT for OEF/OIF Veterans With PTSD and Substance Misuse

Substance Use Disorders | Stress Disorders, Post-traumatic

United States
The Miriam Hospital
National Institute on Drug Abuse (NIDA)

Completed

Exercise to Enhance Smoking Cessation for Women at the YMCA

Smoking

United States
Karolinska Institutet
Region Stockholm

Completed

Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder (IP2)

Panic Disorder

Sweden
Boehringer Ingelheim

Completed

Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers

Healthy

Germany
Cairo University

Recruiting

Effect of Virtual Reality on Upper Extremity Function Post-operative Rotator Cuff Repair

Rotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Impingement Syndrome

Egypt
University of Michigan Rogel Cancer Center
NRG Oncology

Completed

An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors

Cancer-related Cognitive Impairment | Breast Cancer Survivorship

United States
Boehringer Ingelheim

Completed

Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

Healthy
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Life Improvement Following Traumatic Brain Injury (LIFT)

Depression | Traumatic Brain Injury

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Terminated

Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment

Depression | Anxiety | Sickle Cell Disease

United States
Indiana University
Indiana Clinical and Translational Sciences Institute

Terminated

TRAIN Your Sleep; Treating Adolescent Insomnia With Cognitive Behavioral Therapy for Insomnia (CBT-I)

Chronic Pain | Insomnia

United States
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

Neoplasm

Japan
University of Reading
Danisco

Completed

The Effect of a Prebiotic, Probiotic and Synbiotic on the Gut Microbiota and Immune Response of Older Volunteers (GOS)

Gut Microbiota | Immune Function

United Kingdom
LG Life Sciences

Completed

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Hypertension | Hyperlipidemia

Korea, Republic of
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers

Healthy
VA Office of Research and Development

Completed

Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools (REACT (AI CBT))

Back Pain

United States
University of Manitoba

Completed

Impact of Cognitive Behavioral Therapy on Parasomnias (parasomnia)

Parasomnia

Canada
University of Washington
National Institute of Mental Health (NIMH); University of Texas

Completed

Depression and ART Adherence in HIV+ Latinos

HIV Infections | Depressive Symptoms

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Completed

Brief CBT for Anxiety and Advanced Cancer

Depression | Cancer | Anxiety | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive Behavioral Therapy

United States
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Solid Tumor, KRAS Mutation

United States, Taiwan, Japan
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Glioma

Spain, United States, Germany, Netherlands, Austria, Switzerland
Boehringer Ingelheim

Completed

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

Neoplasms

United States, Canada, United Kingdom
Boehringer Ingelheim

Completed

A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

Gastrointestinal Neoplasms | Pancreatic Neoplasms | Cholangiocarcinoma

Spain, Belgium, China, United States, Germany, Korea, Republic of, France, Japan
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1810631 is Taken up in the Body When Taken With or Without Food

Healthy

Germany
University of Pennsylvania

Withdrawn

Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy (BiADLER)

Stroke | Cerebral Palsy

United States
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)

Solid Tumors, KRAS Mutation

Japan
Boehringer Ingelheim

Completed

BI 2536 Second Line Monotherapy in SCLC

Carcinoma, Small Cell

United States, Canada
Boehringer Ingelheim

Completed

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

Healthy

Germany
Boehringer Ingelheim

Completed

Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

Neoplasms

Taiwan
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types

Neoplasms

United Kingdom
Boehringer Ingelheim

Completed

A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Neoplasms

Canada, Netherlands
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

Hepatitis C

Germany
Boehringer Ingelheim

Completed

A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Neoplasms

Japan, Taiwan
Boehringer Ingelheim

Completed

BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia

Leukemia, Myeloid, Acute

Austria, Germany
Boehringer Ingelheim

Completed

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

Healthy

Germany
Boehringer Ingelheim

Completed

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States
Boehringer Ingelheim

Completed

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Schizophrenia | Alzheimer Disease

United States
Universitat Pompeu Fabra
Hospital Universitari Joan XXIII de Tarragona.

Completed

Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)

Hemiparesis
University of California, San Francisco

Completed

Text Messaging and Cognitive Behavioral Therapy for Depression (HealthySMS)

Depression

United States
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Obesity | Non-alcoholic Fatty Liver Disease

United States
Boehringer Ingelheim

Completed

This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body

Healthy

Netherlands
Children's Hospital of Philadelphia
Philips Respironics

Completed

Evaluation of Adherence and Therapeutic Effectiveness of Bi-Flex Versus CPAP in Children With OSA

Obstructive Sleep Apnea

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

Healthy

Germany
University of Missouri, Kansas City

Recruiting

Group CBT in Parents of Children With Food Allergy

Parents

United States
Karolinska Institutet
Karolinska University Hospital

Completed

CBT for Premature Ventricular Contractions (PVC-CBT)

Ventricular Premature Complexes

Sweden
University of Surrey

Completed

Cognitive Behaviour Therapy for Adults With Allergy.

Allergy | Anxiety

United Kingdom

3

Subscribe